arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1807.09212physics.med-ph
收藏

通过多方面放射组学预测多因素癌症治疗结果

Multifactorial cancer treatment outcome prediction through multifaceted radiomics

Zhiguo Zhou, David Sher, Qiongwen Zhang, Pingkun Yan, Jennifer Shah, Nhat-Long Pham, Michael Folkert, Steve Jiang, Jing Wang

摘要:

准确预测治疗结果在癌症治疗中的治疗计划的定制和调整中起着非常重要的作用。尽管不同模式和个性化医疗的发展大大提高了结局预测的准确性,但也同时带来了多模式、多分类器和多标准三大挑战,本文将其概括为多因素结局预测(MFOP)。与传统的结果预测相比,MFOP是一个更广义的问题。为了解决这个新问题,基于最近提出的放射组学,我们提出了一个新的统一的框架,称为多方面放射组学(M-放射组学)。M-radiomics首先训练多个模态特定分类器,然后最佳地组合来自根据多个不同标准(例如灵敏度和特异性)训练的不同分类器的输出的输出。它将多模态、多分类器和多准则纳入一个统一的框架,使预测更加准确。此外,为了获得更可靠的预测性能,即最大化预测输出和标记向量之间的相似性,还提出了一种新的基于验证集的可靠融合(VRF)策略和可靠优化模型,以及一种新的递归两阶段混合优化算法(RTSH)。研究了预测头颈癌远处转移和局部复发的两个临床问题,以验证所提出的M-radiomics的性能和可靠性。通过使用所提出的RF策略和RTSH优化算法,实验结果表明,M-radiomics比目前依赖于单个目标,模态或分类器的放射组学模型表现得更好。

英文摘要:

Accurately predicting the treatment outcome plays a greatly important role in tailoring and adapting a treatment planning in cancer therapy. Although the development of different modalities and personalized medicine can greatly improve the accuracy of outcome prediction, they also bring the three mainly simultaneous challenges including multi-modality, multi-classifier and multi-criteria, which are summarized as multifactorial outcome prediction (MFOP) in this paper. Compared with traditional outcome prediction, MFOP is a more generalized problem. To handle this novel problem, based on the recent proposed radiomics, we propose a new unified framework termed as multifaceted radiomics (M-radiomics). M-radiomics trains multiple modality-specific classifiers first and then optimally combines the output from the outputs of different classifiers which are trained according to multiple different criteria such as sensitivity and specificity. It considers multi-modality, multi-classifier and multi-criteria into a unified framework, which makes the prediction more accurate. Furthermore, to obtain the more reliable predictive performance which is to maximize the similarity between predicted output and labelled vector, a new validation set based reliable fusion (VRF) strategy and reliable optimization models as well as a new recursive two stage hybrid optimization algorithm (RTSH) were also developed. Two clinical problems for predicting distant metastasis and locoregional recurrence in head & neck cancer were investigated to validate the performance and reliability of the proposed M-radiomics. By using the proposed RF strategy and RTSH optimization algorithm, the experimental results demonstrated that M-radiomics performed better than current radiomic models that rely on a single objective, modality or classifier.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑